Magnevist was approved in 1988 by the FDA to “….facilitate the visualization of lesions and abnormal vascularity ….” The pharmaceutical was intended, in other words, for the diagnosis…
Is “Big Pharma” using the same tactics used by “Big Tobacco” to defeat ivermectin? Although researchers such as Richard Doll and Bradford Hill in the…
By Peter Yim WHO updated “Therapeutics and COVID-19” on March 31, 2021 to include a recommendation on ivermectin. The recommendation was: “We recommend not to…
The National Institutes of Health (NIH) updated its COVID-19 Treatment Guidelines recommendation for the use of ivermectin in COVID-19 on January 14, 2021. In that update, the…
A Yale University professor and renowned cancer researcher has pored over the COVID-19 literature and treated several dozen patients. He can remain silent no longer.…
Relative risk reduction and absolute risk reduction measures in the evaluation of clinical trial data are poorly understood by health professionals and the public. The…
The article “Effect of Ivermectin on Time to Resolution of Symptoms Among Adults With Mild COVID-19” was published in the Journal of the American Medical Association on…
A study appeared in JAMA on March 4 showing that: “Among adults with mild COVID-19, a 5-day course of ivermectin, compared with placebo, did not significantly improve…
On March 4, 2021 the Journal of the American Medical Association (JAMA) published results from a clinical trial on ivermectin in COVID-19. The study found…
By Mark Lacy, CEO and Founder of Benchmark Research “This is a wartime effort.” These were the words of President Joe Biden just 5 days…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
